Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9550994
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
granted -
US 9550827
Methods for ameliorating and preventing central nervous system inflammation
granted -
US 9551003
Increasing levels of nicotinic alkaloids in plants
granted -
US 9549934
Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted -
US 9549955
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
granted -
US 9550761
Modulators of ATP-binding cassette transporters
granted -
US 9550757
Nuclear transport modulators and uses thereof
granted -
US 9550742
11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists
granted -
US 9545431
Isolated recombinant cDNA
granted -
US 9546368
Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
granted -
US 9546218
Anti-Tie2 antibodies and uses thereof
granted -
US 9546188
Complexes of germanium with amino acids and carboxylic acids and method for preparing same
granted -
US 9546164
Substituted benzamides and methods of use thereof
granted -
US 9546176
Small molecule bicyclic and tricyclic CFTR correctors
granted -
US 9545451
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
granted -
US 9545443
Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
granted -
US 9545442
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
granted -
US 9545441
Treatment of diabetes
granted -
US 9545461
Anti-microbial peptides and methods of use thereof
granted -
US 9545422
Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells
granted -
US 9545370
Bioactive compositions and methods for their preparation and use
granted -
US 9546370
QSOX1 as an anti-neoplastic drug target
granted -
US 9546151
VMAT inhibitory compounds
granted -
US 9546193
Compositions and methods for 18F-fluorodeoxyglycosylamines
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.